Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (9): 112-117    DOI: 10.13523/j.cb.20170915
    
Advances in Stem Cell 3D Scaffolds
XU Zhu, ZHUGE Qi-chuan, HUANG Li-jie
Department of Neurosurgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China
Download: HTML   PDF(449KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Stem cells are characterized by the capacity of self-renewing and umlimited proliferation and differentiation. They can differentiate into specialized cells under different culture or induced conditions. At present, with the development of medical treatment and stem cell research, it is found that stem cells can be used for the treatment of many diseases. The clinical application of stem cells is in a vast need. However, stem cell transplantation efficiency is very low in vivo. It is still need to figure out the method of stem cells expansion, stable proliferation and differentiation. Currently,the main culture method of the stem cells is still 2D culture. 2D culture can not simulate the 3D microenvironment in the body, and the reproductive efficiency is low. There are emerging results to overcome the limition of 2D culture method by the experts. Here the development and application of 3D culture technologies of stem cells were reviewed.

Key wordsStem cell      3D culture      3D microenvironment      Scaffold     
Received: 26 November 2016      Published: 25 September 2017
ZTFLH:  Q813  
Cite this article:

XU Zhu, ZHUGE Qi-chuan, HUANG Li-jie. Advances in Stem Cell 3D Scaffolds. China Biotechnology, 2017, 37(9): 112-117.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20170915     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I9/112

[1] Marlow R, Dontu G. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures. Methods in Molecular Biology,2015, 1293:1213.
[2] Anton D, Burckel H, Josset E, et al. Three-dimensional cell culture:a breakthrough in vivo. International Journal of Molecular Sciences, 2015, 16(3):5517-5527.
[3] Elliott N T, Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. Journal of Pharmaceutical Sciences, 2011, 100(1):59-74.
[4] Glowacki J, Mizuno S. Collagen scaffolds for tissue engineering. Biopolymers, 2008,89(5):338-344.
[5] Guan J, Zhu Z, Zhao R C, et al. Transplantation of human mesenchymal stem cells loaded on collagen scaffolds for the treatment of traumatic brain injury in rats. Biomaterials, 2013, 34(24):5937-5946.
[6] Laurent T C, Lanrent U B, FraserJ R. Functions of hyaluronan. Annals of the Rheumatic Diseases, 1995, 54(5):429-432.
[7] Lam J, Lowry W E, Carmichael S T, et al. Delivery of iPS-NPCs to the stroke cavity within a hyaluronic acid matrix promotes the differentiation of transplanted cells. Advanced Functional Materials, 2014, 24(44):7053-7062.
[8] Banihashemi M, Mohkam M, Safari A, et al. Optimization of three dimensional culturing of the HepG2 cell line in fibrin scaffold. Hepatitis Monthly, 2015, 15(3):e22731.
[9] Bensai D W, Triffitt J T, Blanchat C, et al. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials, 2003, 24(14):2497-2502.
[10] Dhandayuthapni B, Krishnan U M, Sethuraman S. Fabrication and characterization of chitosan-gelatin blend nanofibers for skin tissue engineering. Journal of Biomedical Materials Research Part B Applied Biomaterials, 2010, 94(1):264-272.
[11] Chen Z, Zhao M, Liu K, et al. Novel chitosan hydrogel formed by ethylene glycol chitosan, 1,6-diisocyanatohexan and polyethylene glycol-400 for tissue engineering scaffold:in vitro and in vivo evaluation. Journal of Materials Science Materials in Medicine, 2014, 25(8):1903-1913.
[12] Malafaya P B, Oliveira J T, Reis R L. The effect of insulin-loaded chitosan particle-aggregated scaffolds in chondrogenic differentiation. Tissue Engineering Part A, 2010, 16(2):735-747.
[13] Charbord P, Livne E, Gross G, et al. Human bone marrow mesenchymal stem cells:a systematic reappraisal via the genostem experience. Stem Cell Reviews & Reports, 2011, 7(1):32-42.
[14] Hu J, Ma P X. Nano-fibrous tissue engineering scaffolds capable of growth factor delivery. Pharmaceutical Research, 2011, 28(6):1273-1281.
[15] Llorens E. Polybiguanide (PHMB) loaded in PLA scaffolds displaying high hydrophobic, biocompatibility and antibacterial properties. Materials Science & Engineering C Materials for Biological Applications, 2015, 50:74-84.
[16] Kim Y C, Kim Y H, Kim J W, et al. Transplantation of mesenchymal stem cells for acute spinal cord Injury in rats:comparative study between intralesional injection and scaffold based transplantation. Journal of Korean Medical Science, 2016, 31(9):1373-1382.
[17] Ouyang A, Ng R, Yang S T. Long-term culturing of undifferentiated embryonic stem cells in conditioned media and three-dimensional fibrous matrices without extracellular matrix coating. Stem Cells, 2007, 25(2):447-454.
[18] Prewitz M, Seib F P, Pompe T, et al. Polymeric biomaterials for stem cell bioengineering. Macromolecular Rapid Communications, 2012, 33(17):1420-1431.
[19] 南文滨, 陈红丽, 刘瑞, 等. 胶原-纤维蛋白胶膜复合脐带间充质干细胞修复小鼠全层皮肤创面的实验研究. 中华损伤与修复杂志,2015,10(1):50-55. Nan W B,Chen H L,Liu R,et al.Umbilical cord mesenchymal stem cell combined with collagen-fibrin double layer membrane accelerates wound healing.Chinese Journal of Injury Repair and Wound Healing,2015,10(1):50-55.
[20] Fan Z, Feng Z, Tao L, et al. Effect of hyaluronan molecular weight on structure and biocompatibility of silk fibroin/hyaluronan scaffolds. International Journal of Biological Macromolecules, 2014, 65(5):516-523.
[21] 姚海军, 赵阳, 周哲,等. 聚己内酯/壳聚糖与聚己内酯/聚乳酸支架与人脂肪来源干细胞的生物相容性研究. 中国男科学杂志, 2015, 29(8):18-22. Yao H J,Zhao Y,Zhou Z,et al.Biocompatibilty analysis of human adipose-derived stem cells and Polycaprolactone/chitosan or polycaprolactone/polylactide scaffold.Chinese Journal of Andrology,2015, 29(8):18-22.
[22] Sambit S, Siew L T, Hong G J C. PLGA nanofiber-coated silk microfibrous scaffold for connective tissue engineering. Journal of Biomedical Materials Research Part B Applied Biomaterials, 2010, 95(1):19-28.
[23] Mousavi S H, Abroun S, Soleimani M, et al. Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin. Int J Hematol Oncol Stem Cell Res,2015, 9(2):72-79.
[24] Bhuiyan D B, Middleton J C, Tannenbaum R, et al. Mechanical properties and osteogenic potential of hydroxyapatite-PLGA-collagen biomaterial for bone regeneration. Journal of Biomaterials Science Polymer Edition, 2016,27(11):1-33.
[25] 张宇, 高思丹, 李俊玲. 纳米材料在组织修复及再生中的应用. 生物技术世界, 2015,(7):227-228. Zhang Y,Gao S D,Li J L.Application of nanomaterials in tissue restoration and regeneration.Biotech World,2015,(7):227-228.
[26] Yang S, Leong K F, Du Z, et al. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Engineering, 2001, 7(6):679-689.
[27] Yang S, Leong K F, Du Z, et al. The design of scaffolds for use in tissue engineering. Part Ⅱ. Rapid prototyping techniques. Tissue Engineering, 2002, 8(1):1-11.
[28] Jessup J M, Frantz M, Sonmez-alpan E, et al. Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line. In Vitro Cellular & Developmental Biology-Animal, 2000, 36(6):367-373.
[29] Vunjak-novakovic G, Freed L E, Biron R J, et al. Effects of mixing on the composition and morphology of tissue-engineered cartilage. Aiche Journal, 2004, 42(3):850-860.
[30] Pathi P, Ma T, Locke B R. Role of nutrient supply on cell growth in bioreactor design for tissue engineering of hematopoietic cells. Biotechnology & Bioengineering, 2005, 89(7):743-758.
[1] QIAN Yu,DING Xiao-yu,LIU Zhi-qiang,YUAN Zeng-qiang. An Efficient Monoclonal Establishment Method of Genetically Modified Human Pluripotent Stem Cells[J]. China Biotechnology, 2021, 41(8): 33-41.
[2] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[3] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[4] ZHAO Jiu-mei,WANG Zhe,LI Xue-ying. Role of Signal Pathways and Related Factors Regulating Cartilage Formation in Bone Differentiation of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(10): 62-72.
[5] CHEN Fei,WANG Xiao-bing,XU Zeng-hui,QIAN Qi-jun. Molecular Mechanism and Clinical Research Progress of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus[J]. China Biotechnology, 2020, 40(7): 59-69.
[6] YU Xing-ge,LIN Kai-li. The Application of Biomaterials Based on Natural Hydrogels in Bone Tissue Engineering[J]. China Biotechnology, 2020, 40(5): 69-77.
[7] DAI Qi-nan,ZHANG Jing-hong. Advances in Molecular Mechanisms Related to Tumor Multi-drug Resistance, Autophagy, DNA Repair and Tumor Stem Cells[J]. China Biotechnology, 2020, 40(4): 69-77.
[8] WANG Yuan-dou,SU Feng,LI Su-ming. Research Progress of Photocrosslinked Hydrogel in Tissue Engineering[J]. China Biotechnology, 2020, 40(4): 91-96.
[9] YUAN Ya-kun,LIU Guang-yang,LIU Yong-jun,XIE Ya-fang,WU Hao. Comparison of Research and Clinical Transformation on Mesenchymal Stem Cells between China and the US[J]. China Biotechnology, 2020, 40(4): 97-107.
[10] YANG Dan,TIAN Hai-shan,LI Xiao-kun. Research Progress of Fibroblast Growth Factor 5[J]. China Biotechnology, 2020, 40(3): 117-124.
[11] CHEN Li-jun,QU Jing-jing,XIANG Charlie. Therapeutic Potentials, Clinical Studies, and Application Prospects of Mesenchymal Stem Cells in 2019 Novel Coronavirus (COVID-19)[J]. China Biotechnology, 2020, 40(11): 43-55.
[12] QIU Dan-dan,LU Cai-xia,DAI Jie-jie. Application of Hepatocyte-like Cells Derived from Induced Pluripotent Stem Cells in HCV Infection Model[J]. China Biotechnology, 2020, 40(11): 67-72.
[13] ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α[J]. China Biotechnology, 2019, 39(9): 62-67.
[14] Hui-rong WU,Zhao-hui WEN. Application of Chitosan in Nerve Tissue Engineering[J]. China Biotechnology, 2019, 39(6): 73-77.
[15] Yue-lei FAN,Jiao LU,Da-ming CHEN,Kai-yun MAO. Strategies for Stem Cell Patent Evaluation and Patent Transfer and Transformation[J]. China Biotechnology, 2019, 39(1): 99-106.